CPC A61K 35/745 (2013.01) [A23L 33/135 (2016.08); A23L 33/16 (2016.08); A23L 33/19 (2016.08); A23L 33/21 (2016.08); A61K 9/0095 (2013.01); A61K 31/733 (2013.01); A61K 35/747 (2013.01); A61K 36/064 (2013.01); A61K 38/063 (2013.01); A61K 38/40 (2013.01); A61K 47/02 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); A23V 2002/00 (2013.01); A61K 2035/11 (2013.01)] | 12 Claims |
1. A probiotic composition for oral administration comprising:
at least about 50 billion CFU/g Bifidobacterium longum R175;
at least about 150 billion CFU/g Lactobacillus helveticus R52;
at least about 150 billion CFU/g Lactobacillus plantarum R1012;
one or more prebiotic components selected from inulin, fructose, fructooligosaccharides and mixtures thereof;
one or more metal salts selected from the group consisting of magnesium gluconate, potassium citrate, copper citrate and zinc gluconate; and
one or more excipients.
|